NCT02944487View on ClinicalTrials.gov

A Study to Assess the Safety and Pharmacokinetics of Lucerastat (OGT 923) in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

December 31, 2002

Study Completion Date

December 31, 2002

Conditions
Healthy Subjects
Interventions
DRUG

Lucerastat

Hard gelatin capsule for oral administration containing lucerastat

DRUG

Placebo

Matching placebo capsules

Trial Locations (1)

EH33 2NE

Investigator Site, Tranent

Sponsors
All Listed Sponsors
lead

Idorsia Pharmaceuticals Ltd.

INDUSTRY